Please Wait
Applying Filters...
menu
    • menu
    Chirogate-PSE
    News
    Lupin Receives FDA Approval for Ranluspec (Ranibizumab)

    05 Jun 2026

    // PR NEWSWIRE

    Pacira Reminds Stockholders to Vote BLUE Proxy Ahead of AGM

    05 Jun 2026

    // PR NEWSWIRE

    ADC Therapeutics' Ph3: ZYNLONTA + Rituximab Results in r/r DLBCL

    05 Jun 2026

    // PR NEWSWIRE

    DATA COMPILATION
    #PharmaFlow

    Chirogate VB RM

    Contact Supplier

    Website

    CPhI China

    Booth #E1D22b

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/prostaglandin-market-to-cross-us-1-27-bn-by-2035-liquidia-s-yutrepia-okayed-for-pulmonary-hypertension
    Menu

    Chirogate International

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Chirogate International Inc.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    CPhI China
    Booth #E1D22b

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2025-07-29

    Chirogate International

    City : Taoyuan City

    State :

    Country/Area : Taiwan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2025-07-29

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    CPhI China
    Booth #E1D22b

    District Decision : No Action Indicated

    Inspection End Date : 2018-12-06

    Chirogate International

    City : Taoyuan City

    State :

    Country/Area : Taiwan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2018-12-06

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    arrow
    CPhI China
    Booth #E1D22b

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-23

    Chirogate International

    City : Taoyuan City

    State :

    Country/Area : Taiwan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-23

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    arrow
    CPhI China
    Booth #E1D22b

    District Decision : No Action Indicated

    Inspection End Date : 2010-10-27

    Chirogate International

    City : Taoyuan City

    State :

    Country/Area : Taiwan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2010-10-27

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    arrow
    CPhI China
    Booth #E1D22b

    District Decision : No Action Indicated

    Inspection End Date : 2010-10-27

    Chirogate International

    City : Taoyuan City

    State :

    Country/Area : Taiwan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2010-10-27

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    arrow
    CPhI China
    Booth #E1D22b

    District Decision : No Action Indicated

    Inspection End Date : 2010-10-27

    Chirogate International

    City : Taoyuan City

    State :

    Country/Area : Taiwan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2010-10-27

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Chirogate International and get a quotation

    Chirogate International is a supplier offers 18 products (APIs, Excipients or Intermediates).

    Find Latanoprost bulk with DMF, CEP, JDMF offered by Chirogate International

    Find Carboprost Tromethamine bulk with DMF, CEP offered by Chirogate International

    Find Latanoprost bulk with DMF, JDMF offered by Chirogate International

    Find Tafluprost bulk with DMF, JDMF offered by Chirogate International

    Find Bimatoprost bulk with DMF offered by Chirogate International

    Find Dinoprostone bulk with DMF offered by Chirogate International

    Find Iloprost bulk with DMF offered by Chirogate International

    Find Latanoprostene Bunod bulk with DMF offered by Chirogate International

    Find Travoprost bulk with DMF offered by Chirogate International

    Find Treprostinil Sodium bulk with DMF offered by Chirogate International

    Find Alprostadil bulk offered by Chirogate International

    Find Beraprost Sodium bulk offered by Chirogate International

    Find Dinoprost bulk offered by Chirogate International

    Find Dinoprost Tromethamine bulk offered by Chirogate International

    Find Epoprostenol Sodium bulk offered by Chirogate International

    Find Lubiprostone bulk offered by Chirogate International

    Find Misoprostol bulk offered by Chirogate International

    Find Treprostinil Diolamine bulk offered by Chirogate International

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.